Real-time enrollment status for this bladder cancer clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 6:12 PM UTC
| NCT Number | NCT03216525 |
| Recruiting Status | Recruiting |
| Condition | Bladder Cancer |
| Phase | PHASE3 |
| Target Enrollment | 136 participants |
| Active Locations | 1 sites in the US |
| Sponsor | Brigham and Women's Hospital |
| Last Updated on CT.gov | September 28, 2023 (Sep 28, 2023) |
As of August 31, 2026: Clinical trial NCT03216525 is currently recruiting participants. This phase3 study for bladder cancer is actively seeking new participants at 1 location across the United States. The study is sponsored by Brigham and Women's Hospital. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT03216525 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT03216525 was last updated Sep 28, 2023 (September 28, 2023). HelloStudys verifies this status automatically.